How Strata plans to sequence 100K tumors for free
Strata Oncology might be the missing piece in personalized cancer care. The company plans to sequence 100,000 tumor samples for free, matching eligible patients with ongoing pharma trials. Patients, pharma and Strata all win -- if they can pull it off.
